Skip to main content

Table 6 Demographic, clinical and biochemical parameters among recurrent and eradicated HCC cases

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter

Recurrent HCC cases (n=6)

Eradicated HCC cases (n=30)

p

Age (years)

62.8±3.1

56 ±6.9

< 0.001

BMI (Kg/m2)

24.5±1.6

24.7±2.3

0.869

Gender

Male n (%)

5 (83.3)

20 (66.7)

0.643a

Female n (%)

1 (16.7)

10 (33.3)

Child-Pugh score

7.2±0.8

5.9±1.0

0.008

ALT (U/L)

67.8±38.9

54.3±26.2

0.295

AST (U/L)

62.8±41.4

56.8±29.5

0.672

ALP (U/L)

80.0±24.5

79.5±24.7

0.964

S. albumin (g/dl)

3.3±0.2

3.7±0.4

0.036

T. bilirubin (mg/dl)

1.7±0.5

1.5±0.4

0.198

D. bilirubin (mg/dl)

0.8±0.2

0.7±0.2

0.119

INR

1.6±0.4

1.3±0.4

0.118

Hemoglobin (g/dL)

9.6±1.9

10.2±1.4

0.358

WBCs (× 103/mL)

4.2±2.4

5.3±2.3

0.301

Platelets (× 103/mL)

159.2±21.6

146.2±37.4

0.42

S. creatinine (mg/dL)

0.92±0.33

0.84±0.34

0.598

S. sodium (mEq/L)

137.3±4.1

137.5±3.7

0.907

S. potassium (mEq/L)

4.1±0.7

4.0±0.5

0.841

Number of HCC lesions

3.0±0.0

1.7±0.7

< 0.001

Size of HCC lesions (cm)

6.2±1.6

3.3±1.2

< 0.001

  1. aFisher’s exact test